All CIRS research papers

7,510 papers, newest first · page 82 of 126

  1. TGF-? receptor function in the endothelium

    Cardiovascular Research · 2005

  2. Imatinib for the Treatment of Pulmonary Arterial Hypertension

    New England Journal of Medicine · 2005

  3. Annals of Pharmacotherapy

    2005

  4. Sildenafil citrate therapy for pulmonary arterial hypertension

    Yearbook of Cardiology · 2005

  5. Inhaled nitric oxide therapy in adults

    New England Journal of Medicine · 2005

  6. Continuous haemodynamic monitoring during exercise in patients with pulmonary hypertension

    International Journal of Cardiology · 2005

  7. Bosentan improves exercise tolerance and tei index in patients with pulmonary hypertension and prostanoid therapy

    CHEST Journal · 2005

  8. Iloprost inhalation solution for the treatment of pulmonary arterial hypertension

    Expert Opinion on Pharmacotherapy · 2005

  9. Prostacyclin Therapy for Pulmonary Arterial Hypertension

    Contemporary Cardiology™ · 2005

  10. Long-term echocardiographic follow-up of a patient with primary pulmonary hypertension receiving iloprost inhalations

    European Journal of Echocardiography · 2005

  11. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders

    Proceedings of the National Academy of Sciences · 2005

  12. Acute oxygen-sensing mechanisms

    New England Journal of Medicine · 2005

  13. Human VIP-α: an emerging biologic response modifier to treat primary pulmonary hypertension

    Expert Review of Cardiovascular Therapy · 2005

  14. Arginine vasopressin and vasoactive intestinal polypeptide fibers make appositions with gonadotropin-releasing hormone and estrogen receptor cells in the diurnal rodent Arvicanthis niloticus

    Brain Research · 2005

  15. Neuroprotective potential of threee neuropeptides PACAP, VIP and PHI

    Pharmacological Reports · 2005

  16. Journal of Leukocyte Biology

    Journal of Leukocyte Biology · 2005

  17. Nerve growth factor restores the expression of vasopressin and vasoactive intestinal polypeptide in the suprachiasmatic nucleus of aged rats

    Brain Research · 2005

  18. Vasoactive Intestinal Peptide Ameliorates Synovial Cell Functions of Collagen-Induced Arthritis Rats by Down-Regulating NF-κB Activity

    Immunological Investigations · 2005

  19. Arginine-vasopressin and vasointestinal polypeptide rhythms in the suprachiasmatic nucleus of the mouse lemur reveal aging-related alterations of circadian pacemaker neurons in a non-human primate

    European Journal of Neuroscience · 2005

  20. Manuscript submitted

    2005

  21. Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-κB, in mouse calvarial osteoblasts

    Bone · 2005

  22. cDNA Array Analysis of Cytokines, Chemokines, and Receptors Involved in the Development of TNBS-Induced Colitis: Homeostatic Role of VIP

    Inflammatory Bowel Diseases · 2005

  23. The changes in circulating levels of vasoactive intestinal polypeptide during exercise and its reproducibility for detection of myocardial ischemia

    International Heart Journal · 2005

  24. Brain Res

    2005

  25. Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: Antagonistic action of a growth-hormone-releasing hormone analog

    International Journal of Oncology · 2005

  26. Vasoactive Intestinal Peptide and Corticotropin-Releasing Hormone Increase ??-Endorphin Release and Proopiomelanocortin Messenger RNA Levels in Primary Cultures of Hypothalamic Cells: Effects of Acute and Chronic Ethanol Treatment

    Alcoholism Clinical and Experimental Research · 2005

  27. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP

    Journal of Leukocyte Biology · 2005

  28. Cardioprotective role of the VIP signaling system

    Drug News & Perspectives · 2005

  29. Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders

    Medical Hypotheses · 2005

  30. Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?

    Medical Hypotheses · 2005

  31. Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?

    Medical Hypotheses · 2005

  32. Long-lasting effects of serotonin deficiency on differentiating peptidergic neurons in the rat suprachiasmatic nucleus

    International Journal of Developmental Neuroscience · 2005

  33. Vasoactive intestinal polypeptide (VIP) is not an androgen-dependent neuromediator of penile erection

    International Journal of Impotence Research · 2005

  34. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

    Journal of Leukocyte Biology · 2005

  35. Role of vasoactive intestinal peptide in inflammation and autoimmunity

    Curr Opin Investig Drugs · 2005

  36. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells

    The Journal of Immunology · 2005

  37. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 And VPAC2 receptors

    Brain Research · 2005

  38. Guinea-pig lung adenylyl and guanylyl cyclase and PDE activities associated with airway hyper- and hypo-reactivity following LPS inhalation

    Life Sciences · 2005

  39. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation

    Biochemical Pharmacology · 2005

  40. Regulation of cyclic nucleotides in the urinary tract

    Journal of Smooth Muscle Research · 2005

  41. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors

    Journal of Pharmacology and Experimental Therapeutics · 2005

  42. Occupational exposure to crystalline silica dust in the United States, 1988-2003

    Environmental Health Perspectives · 2005

  43. The induction of vascular endothelial growth factor by ultrafine carbon black contributes to the increase of alveolar-capillary permeability

    Environmental Health Perspectives · 2005

  44. Effect of Maternal Smoking on Breast Milk Interleukin-1α, β-Endorphin, and Leptin Concentrations

    Environmental Health Perspectives · 2005

  45. Induction of proinflammatory cytokines and c-reactive protein in human macrophage cell line U937 exposed to air pollution particulates

    Environmental Health Perspectives · 2005

  46. Associations between health effects and particulate matter and black carbon in subjects with respiratory disease

    Environmental Health Perspectives · 2005

  47. Workgroup report: workshop on source apportionment of particulate matter health effects-intercomparison of results and implications

    Environmental Health Perspectives · 2005

  48. Platelet physiology and thrombosis

    Thrombosis Research · 2004

  49. Signalling through the platelet glycoprotein Ib-V–IX complex

    Cellular Signalling · 2004

  50. Detection of streptomycetes in house dust - comparison of culture and PCR methods

    Indoor Air · 2004

  51. Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarum

    Environmental Health Perspectives · 2004

  52. Comparison of inflammatory and cytotoxic lung responses in mice after intratracheal exposure to spores of two different Stachybotrys chartarum strains

    Toxicological Sciences · 2004

  53. Localization of Satratoxin-G in Stachybotrys chartarum Spores and Spore-Impacted Mouse Lung Using Immunocytochemistry

    Toxicologic Pathology · 2004

  54. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect

    La Clinica terapeutica · 2004

  55. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease

    Seminars in Immunology · 2004

  56. Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma

    Clinical & Experimental Allergy · 2004

  57. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)‐β1, TGF‐β2, interleukin (IL)‐4 and IL‐13 after segmental allergen challenge and their effects on α‐smooth muscle actin and collagen III synthesis by primary human lung fibroblasts

    Clinical & Experimental Allergy · 2004

  58. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis

    Clinical Neurology and Neurosurgery · 2004

  59. Cognitive impairment: classification by 1H magnetic resonance spectroscopy

    European Journal of Neurology · 2004

  60. Smaller hippocampal volume in patients with recent-onset posttraumatic stress disorder

    Biological Psychiatry · 2004